ScienceDaily describes research at University of Virginia Health System to develop a vaccine to stimulate the immune system to attack and suppress melanoma tumors.
Link: ScienceDaily: Potential New Target For Skin Cancer Treatment
When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin. According to researchers at the University of Virginia Health System, some of these genes are normally active in the male testis at the time sperm are formed.
The genes, called cancer-testis antigens, could be useful targets for drugs that could selectively kill a melanoma tumor, while sparing the rest of the body's tissues. The antigens could also help researchers develop a vaccine to stimulate the immune system to attack and suppress melanoma tumors.
"Scientists are beginning to see patterns in the profile of genes expressed in individual tumor cells," said John C. Herr, Ph.D., professor of cell biology at UVa and a scientist at the UVa Cancer Center. " Patients who express a given cancer-testis antigen may eventually be helped by such selective therapies. This scenario represents one aspect of the growing opportunities envisioned for personalized medicine."
Scientists at the UVa Cancer Center have studied melanoma tumors from patients at various stages of the disease over the last few years. They discovered that more than half of these tumors made the cancer-testis antigens, called SPANX proteins. In a study published in the Sept. 29, 2006 online edition of the Journal Molecular Human Reproduction, Herr and his UVa research team showed that the SPANX proteins play a role in the formation of the nuclear envelope of the developing human spermatid.
One of the intriguing features about the SPANX proteins is that two gene locations, for familial forms of prostate and testicular cancer, map to the SPANX region on the X chromosome. "These findings underscore the need to better understand the function of this rapidly evolving gene family" Herr said.
Source: University of Virginia Health System
i
Comments